ADIPEARL

Live / Registered — Registered (as of 23 Dec 2025)

What this means for you

Registered since 23 Dec 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98610045
Registration number
8073554
Mark type
Stylized text
Filed
20 Jun 2024
Published for opposition
04 Nov 2025
Registered
23 Dec 2025
Attorney of record
Amy C. Ziegler

Goods and services

  • Class 001 — Chemicals: Chemical polymers for use in the manufacture of pharmaceutical preparations and medical implants; biodegradable polymer compositions for use in the manufacture of pharmaceutical preparations and medical implants
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations, in particular for tissue enhancement and reconstruction, for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for aesthetic medicine, for reconstructive medicine and for reconstructive surgery; medical and veterinary preparations and articles, in particular medical and veterinary preparations for treating the loss of soft tissue volume as well as for improving skin quality and volume contours in dermatology for tissue enhancement and reconstruction; pre-filled syringes filled with pharmaceutical preparations for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for medical purposes; Pre-filled vials filled with pharmaceutical preparations for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for medical and aesthetic medicine purposes; vials and syringes, pre-filled with a medical preparation for enabling cellular or tissular assembly for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for aesthetic and medical purposes; injectable dermal fillers; biological implants, namely, implants comprising living tissue; implantable medicines for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology; injectable materials in the nature of injectable gels for treating the loss of soft tissue volume in humans for tissue repair, enhancement, creation or regeneration; implantable materials in the nature of injectable gels for treating the loss of soft tissue volume in humans containing an anaesthetic agent or a pharmaceutical ingredient; injectable materials in the nature of injectable gels for treating the loss of soft tissue volume in humans containing an anaesthetic agent or a pharmaceutical ingredient; none of the aforementioned in relation to medication and drugs for preventing, curing or slowing down the progression of cancer; polysaccharide compositions in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for use in the dermal filler industry; polymeric biomaterials, in particular polymeric biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology for use in the cell therapy industry; injectable biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology, in particular for use in aesthetic medicine, aesthetic surgery, reconstructive surgery; injectable biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology in the form of microgels; injectable biomaterials in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours in dermatology in the form of particles, in the form of paste or putty, in the form of a dry material; implantable biomaterials in the nature of pharmaceutical preparations for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours, in particular for enhancing or creating new skin volumes or skin layers, in the form of three-dimensional volumes; injectable biocompatible material in the nature of injectable gels for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours, in particular for enhancing or creating new skin volumes or skin layers, in dermatology used for tissues in particular soft tissues
  • Class 010 — Medical apparatus: Surgical apparatus and instruments; prosthetic and filling materials, namely artificial materials for use in the replacement of soft tissue in humans, and artificial implants; artificial breast implants; medical implants made of artificial materials; biodegradable implants consisting of artificial materials; scaffolding material for the use of three-dimensional shapeable body implants, namely, implantable scaffolds comprising artificial materials for creating new tissue volume or to compensate for tissue volume loss and serving as a scaffold for the regeneration of human tissue; artificial materials for the repair and enhancement of human tissue, namely, implantable scaffolds comprising artificial materials for creating new tissue volume or to compensate for tissue volume loss and serving as a scaffold for the regeneration of human tissue; suture materials; syringes for injections; syringes, vials, containers and sterile bags sold together as medical apparatus for preparing a cellular or tissular construct, for preparing a pharmaceutical composition, and for mixing the composition with an anesthetic agent for treating the loss of soft tissue volume in humans as well as for improving skin quality and volume contours, in particular for enhancing or creating new skin volumes or skin layers in dermatology or plastic surgery for use in the dermal filler industry or tissue reconstruction and enhancement industry, or in the regenerative medicine industry; medical injection syringes; syringes for medical use; medical syringes for use in aesthetic surgery, in particular, in dermatology and reconstructive surgery; pharmaceutical implants made of artificial materials; implants made of artificial materials for guided tissue regeneration.

Owner

Prosecution history

  • 15 Jan 2026 — TEAS SECTION 7 REQUEST RECEIVED
  • 23 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 23 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
  • 04 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 04 Nov 2025 — PUBLISHED FOR OPPOSITION
  • 29 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 02 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 15 Sept 2025 — EXAMINER'S AMENDMENT ENTERED
  • 15 Sept 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 15 Sept 2025 — EXAMINERS AMENDMENT E-MAILED
  • 15 Sept 2025 — EXAMINERS AMENDMENT -WRITTEN
  • 10 Jul 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
  • 10 Jul 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
  • 15 Apr 2025 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
  • 15 Apr 2025 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

View this trademark record on Marksy